Park Medi World Ltd. has opened its first hospital in Uttarakhand, a 330-bed facility named 'The Medicity Hospital' in Rudrapur. This marks expansion into its sixth North Indian state. The company aims to reach 5,600 beds by March 2028.
Jubilant Pharmova reported a 14% revenue jump to ₹8,279.6 crore for FY26, driven by its CDMO Sterile Injectables and Generics segments. The company recommended a ₹5 per share dividend, but EBITDA margins faced pressure from facility issues.
Kilitch Drugs India reported an 18.7% rise in FY26 revenue to ₹235.47 crore and an 18.3% increase in net profit to ₹29.50 crore. The company also commissioned a new manufacturing facility in Maharashtra, designed to meet global regulator...
Aarti Drugs reported a 19% year-on-year increase in revenue to ₹703.6 crore for Q1 FY27. EBITDA grew 30% to ₹96.9 crore with margins expanding. However, Profit After Tax saw a 7% decline to ₹50.1 crore, partly due to a one-time tax refun...
Zydus Lifesciences' injectable facility in Ahmedabad received a Voluntary Action Indicated (VAI) classification from the USFDA. This means the US FDA found areas for improvement but isn't recommending enforcement action, providing regula...
Hester Biosciences reported strong standalone growth with revenue up 14% and PAT up 88% YoY, driven by its Poultry Healthcare division. However, consolidated revenue declined 8% due to international issues.
Apollo Hospitals reported strong FY26 results with consolidated revenue rising 16% to ₹25,228.5 crore and PAT growing 33% to ₹2,002.7 crore. The company also proposed demerging its digital and pharmacy businesses.
Divis Laboratories posted robust Q1 FY27 results, with consolidated revenue at ₹3,080 crore and profit at ₹902 crore, a 65% year-over-year increase. The company also appointed two senior management personnel for procurement.
Dr Reddy's Laboratories announced U.S. FDA approval for its rituximab biosimilar, a drug for treating certain cancers and autoimmune diseases. The company partnered with Fresenius Kabi for U.S. commercialization. This validates their com...
Neuland Laboratories announced the start of commercial production at expanded facilities in two Telangana units. This marks a key operational milestone, enabling increased manufacturing output.